KRAS mutations in gastrointestinal cancers: New insights from pathogenic mechanisms to therapeutic challenges
Journal of Pharmaceutical Analysis · 2026-07 · 101718
DOI: 10.1016/j.jpha.2026.101718 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Analysis, 2026-07. Verfasst von Xiaojuan Yang und 10 weiteren Autor:innen. Die Arbeit nennt 228 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Foundation for Innovative Research Groups of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China
Zitieren
APA
Yang, X., Tao, X., Qi, W., Luo, R., Lan, T., Xie, K., Cai, Y., Gao, F., Lv, Y., Liu, C., & Wu, H. (2026). KRAS mutations in gastrointestinal cancers: New insights from pathogenic mechanisms to therapeutic challenges. Journal of Pharmaceutical Analysis, 101718. https://doi.org/10.1016/j.jpha.2026.101718
Vancouver
Yang X, Tao X, Qi W, Luo R, Lan T, Xie K, et al. KRAS mutations in gastrointestinal cancers: New insights from pathogenic mechanisms to therapeutic challenges. Journal of Pharmaceutical Analysis. 2026:101718. doi:10.1016/j.jpha.2026.101718
BibTeX
@article{Yang2026,
author = {Yang, Xiaojuan and Tao, Xue and Qi, Weili and Luo, Ruihan and Lan, Tian and Xie, Kunlin and Cai, Yunshi and Gao, Fengwei and Lv, Yinghao and Liu, Chang and Wu, Hong},
title = {KRAS mutations in gastrointestinal cancers: New insights from pathogenic mechanisms to therapeutic challenges},
journal = {Journal of Pharmaceutical Analysis},
year = {2026},
pages = {101718},
doi = {10.1016/j.jpha.2026.101718}
}
EUVIMED